$135 Million is the total value of Daventry Group, LP's 7 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | $22,135,050 | +11.0% | 155,552 | 0.0% | 16.38% | +17.4% | |
| HCAT | HEALTH CATALYST INC | $20,463,888 | +7.1% | 1,637,111 | 0.0% | 15.15% | +13.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TENABLE HLDGS INC | 8 | Q3 2023 | 22.5% |
| ELASTIC N V | 8 | Q3 2023 | 17.5% |
| HEALTH CATALYST INC | 8 | Q3 2023 | 16.8% |
| PTC INC | 8 | Q3 2023 | 16.4% |
| EVERBRIDGE INC | 7 | Q3 2023 | 13.6% |
| NEW RELIC INC | 6 | Q3 2023 | 15.0% |
| OAK STR HEALTH INC | 5 | Q4 2022 | 17.6% |
| CHARLES RIV LABS INTL INC | 3 | Q3 2023 | 11.1% |
| SAILPOINT TECHNOLOGIES HLDGS | 2 | Q1 2022 | 23.2% |
| HASHICORP INC | 1 | Q3 2023 | 11.4% |
View Daventry Group, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Daventry Group, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.